Fischer Laurent
Insider CIK 1379344 · TBRA Chief Executive Officer, Director · ADVM CEO, President and Director, Director · MIRM Director · LYCA Director · ATAI Director · ATAI Director · CTIC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYCA Lycia Therapeutics, Inc. | A Award deriv | 2026-10-22 | 2026-10-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 121,968 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 206,000 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 103,000 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 121,968 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 103,000 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 206,000 | — | — | 0 | SEC↗ |
| LYCA Lycia Therapeutics, Inc. | A Award deriv | 2026-08-11 | 2026-10-26 | 13,307 | — | $0 | 13,307 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 3,772 | — | $0 | 3,772 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 1,980 | — | $0 | 1,980 | SEC↗ |
| ATAI AtaiBeckley Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 121,968 | — | $0 | 121,968 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-05-29 | 2026-06-02 | 3,977 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-05-29 | 2026-06-02 | 3,977 | — | $0 | 10,727 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 93,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 200,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2025-12-09 | 2025-12-10 | 150,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 120,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 68,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 45,499 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 63,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 67,502 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 58,497 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 31,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 110,420 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 522,666 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2025-12-09 | 2025-12-10 | 500,000 | — | $0 | 522,666 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 25,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 351,513 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2025-12-09 | 2025-12-10 | 150,000 | $4.20 | $630.0K | 351,513 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2025-12-08 | 2025-12-08 | 117,614 | $4.31 | $506.9K | 201,513 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2025-12-05 | 2025-12-08 | 11,085 | $4.24 | $47.0K | 83,899 | SEC↗ |
| ATAI ATAI Life Sciences N.V. | A Award deriv | 2025-06-26 | 2025-06-27 | 103,000 | — | $0 | 103,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 45,499 | — | $0 | 45,499 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 120,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 68,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 68,000 | — | $0 | 68,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 110,420 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 67,502 | — | $0 | 67,502 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 67,502 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 58,497 | — | $0 | 58,497 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 58,497 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 31,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 63,000 | — | $0 | 63,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 63,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 110,420 | — | $0 | 110,420 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 45,499 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 3,977 | — | $0 | 3,977 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 6,268 | — | $0 | 6,268 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2025-05-15 | 2025-05-16 | 9,126 | $2.00 | $18.3K | 87,488 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-02-25 | 2025-02-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2025-02-25 | 2025-02-27 | 25,000 | — | $0 | 96,614 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-08-02 | 2024-08-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ATAI ATAI Life Sciences N.V. | A Award deriv | 2024-06-13 | 2024-06-14 | 206,000 | — | $0 | 206,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 8,779 | — | $0 | 8,779 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 5,703 | — | $0 | 5,703 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-02-12 | 2024-02-14 | 1,104,200 | — | $0 | 1,104,200 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-10-03 | 2024-03-12 | 315,000 | — | $0 | 315,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 126,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 60,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 50,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 120,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 80,000 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2023-04-05 | 2023-04-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2023-03-15 | 2023-03-17 | 41,239 | $0.78 | $32.2K | 692,141 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-03-01 | 2023-03-03 | 930,000 | — | $0 | 930,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2022-09-19 | 2022-09-21 | 41,082 | $1.07 | $44.0K | 727,380 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-09-14 | 2022-09-16 | 584,978 | — | $0 | 584,978 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-09-14 | 2022-09-16 | 675,022 | — | $0 | 675,022 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2022-06-02 | 2022-06-06 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2022-04-20 | 2022-04-22 | 25,000 | $1.11 | $27.8K | 762,462 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2022-03-09 | 2022-03-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-03-08 | 2022-03-17 | 630,000 | — | $0 | 630,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2021-12-09 | 2021-12-10 | 14,323 | $1.85 | $26.5K | 737,462 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2021-12-08 | 2021-12-10 | 10,677 | $1.79 | $19.1K | 723,139 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-08-06 | 2021-08-10 | 455,000 | — | $0 | 455,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2021-08-06 | 2021-08-10 | 680,000 | — | $0 | 706,292 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2021-06-04 | 2021-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2021-03-24 | 2021-03-24 | 10,000 | $9.88 | $98.8K | 26,292 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2021-03-10 | 2021-03-12 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-02-16 | 2021-02-18 | 680,000 | — | $0 | 680,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2021-01-15 | 2021-01-19 | 8,600 | $11.53 | $99.2K | 16,292 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2020-08-17 | 2020-08-19 | 7,692 | $13.00 | $100.0K | 7,692 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-06-15 | 2020-06-17 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-15 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2020-03-11 | 2020-03-13 | 126,000 | — | $0 | 126,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-17 | 2019-09-18 | 1,648 | $9.37 | $15.4K | 6,750 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-16 | 2019-09-18 | 452 | $9.47 | $4.3K | 5,102 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-10 | 2019-09-10 | 960 | $10.29 | $9.9K | 4,650 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-09 | 2019-09-10 | 1,670 | $10.54 | $17.6K | 3,390 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-09 | 2019-09-10 | 300 | $11.30 | $3.4K | 3,690 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-06 | 2019-09-10 | 1,720 | $10.71 | $18.4K | 1,720 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2019-05-16 | 2019-05-20 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2018-05-17 | 2018-05-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2017-07-21 | 2017-07-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 16,416 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 105,000 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 503,882 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 83,324 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 258,000 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 53,616 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 4,332 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 4,332 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 258,000 | — | $0 | 258,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-05-15 | 2015-05-18 | 105,000 | — | $0 | 105,000 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 83,324 | — | $0 | 168,789 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 4,332 | — | $0 | 4,332 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 4,332 | — | $0 | 8,664 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 53,616 | — | $0 | 62,280 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 503,882 | — | $0 | 672,671 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 6,769 | — | $0 | 85,465 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 16,416 | — | $0 | 78,696 | SEC↗ |